[Results of treatment with a pimaricin-neomycin-hydrocortisone ointment].
D000152:Acne Vulgaris / Q000188:drug therapy; D000287:Administration, Topical; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D002175:Candida; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D004357:Drug Synergism; D005499:Folliculitis / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone; D010866:Natamycin; D009355:Neomycin / Q000008:administration & dosage*; D009617:Nocardia Infections / Q000188:drug therapy; D009824:Ointments; D012393:Rosacea / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D014005:Tinea / Q000188:drug therapy
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D009824:Ointments; D010866:Natamycin; D009355:Neomycin; D006854:Hydrocortisone
Behandlungsergebnisse mit einer Pimaricin-Neomycin-Hydrokortisonsalbe.